MedTrace Logo

Identification and Semi-Quantification of Ki-67 Protein Expression Status

NCT02654457 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2016-01-13

No results posted yet for this study

Summary

The purpose of the study is the identification and semi-quantification of Ki-67 protein expression level in breast cancer tissues by the GenASIs GoPth system as compared to manual reading of the same slides.

The imaging system is intended for diagnostic use as an aid to the pathologist in the detection, counting and classifying ER/PR IHC stained samples

Conditions

Interventions

PROCEDURE

Women with Breast Cancer

IVD Study

Sponsors & Collaborators

  • Applied Spectral Imaging Ltd.

    lead INDUSTRY

Eligibility

Min Age
21 Years
Max Age
89 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-05-31
Completion
2015-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02654457 on ClinicalTrials.gov